CN116121068A - Application system of 3D cell culture perfusion bioreactor and cell culture method - Google Patents
Application system of 3D cell culture perfusion bioreactor and cell culture method Download PDFInfo
- Publication number
- CN116121068A CN116121068A CN202211446147.4A CN202211446147A CN116121068A CN 116121068 A CN116121068 A CN 116121068A CN 202211446147 A CN202211446147 A CN 202211446147A CN 116121068 A CN116121068 A CN 116121068A
- Authority
- CN
- China
- Prior art keywords
- capillary
- chamber
- bioreactor
- liquid
- cell culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012604 3D cell culture Methods 0.000 title claims abstract description 20
- 230000010412 perfusion Effects 0.000 title claims abstract description 18
- 238000004113 cell culture Methods 0.000 title claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 136
- 238000012258 culturing Methods 0.000 claims abstract description 3
- 239000002699 waste material Substances 0.000 claims description 17
- 238000010992 reflux Methods 0.000 claims description 16
- 230000002503 metabolic effect Effects 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 10
- 239000001963 growth medium Substances 0.000 claims description 9
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 230000004663 cell proliferation Effects 0.000 claims description 5
- 230000010261 cell growth Effects 0.000 claims description 4
- 230000007613 environmental effect Effects 0.000 claims description 4
- 230000008614 cellular interaction Effects 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 238000010899 nucleation Methods 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 230000006399 behavior Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 39
- 239000002207 metabolite Substances 0.000 description 20
- 230000032258 transport Effects 0.000 description 11
- 235000015097 nutrients Nutrition 0.000 description 7
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 238000012605 2D cell culture Methods 0.000 description 4
- 238000010146 3D printing Methods 0.000 description 4
- 206010016754 Flashback Diseases 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000003278 mimic effect Effects 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000008619 cell matrix interaction Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011295 pitch Substances 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/48—Holding appliances; Racks; Supports
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/18—External loop; Means for reintroduction of fermented biomass or liquid percolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Clinical Laboratory Science (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于细胞生物学和组织工程领域,具体涉及3D细胞培养灌注生物反应器的应用体系和细胞培养方法。The invention belongs to the fields of cell biology and tissue engineering, and in particular relates to an application system of a 3D cell culture perfusion bioreactor and a cell culture method.
背景技术Background technique
近年来,药物研发致力于使用细胞体外培养模型模拟人体的体内情况。传统的培养方式是,将特定数量或浓度的细胞接种到微孔板上。在进行规定的测定之前,培养微孔板支持细胞附着在二维(2D)的单分子层上。虽然这有一些改进,但用这种2D方式培养细胞仍然存在问题,至少2D细胞培养模型通常不能准确模拟体内环境条件和/或细胞行为。In recent years, drug development has focused on using in vitro culture models of cells to mimic the in vivo conditions of the human body. The traditional culture method is to seed a specific number or concentration of cells on a microwell plate. Microwell plates are cultured to support cells attached to a two-dimensional (2D) monolayer prior to performing the prescribed assays. While this represents some improvement, growing cells in this 2D fashion is still problematic, at least 2D cell culture models often do not accurately mimic in vivo environmental conditions and/or cell behavior.
举例而言,在二维细胞培养模型中,候选抗癌药物的损耗率高达95%,导致体外评价出的药物疗效无法为临床应用提供指导。甚至还可能出现不可预见的毒性问题。其原因如下:首先,在二维细胞培养模型中,一些细胞外基质(ECM)成分缺失,导致某些细胞与细胞间、细胞与基质间的相互作用不会发生。这些细胞外基质成分和相互作用对细胞分化、细胞增殖和/或正常发生在体内的细胞功能至关重要。其次,已经发现二维细胞培养模型的环境不能准确地模拟活体三维(3D)癌细胞驻留的环境,因为2D环境下不存在缺氧区域、异质细胞群、不同的细胞增殖区、ECM影响、可溶性信号梯度和/或差异营养和代谢废物运输。For example, in a two-dimensional cell culture model, the loss rate of candidate anticancer drugs is as high as 95%, so that the drug efficacy evaluated in vitro cannot provide guidance for clinical application. There may even be unforeseen toxicity issues. The reasons for this are as follows: First, some extracellular matrix (ECM) components are missing in the 2D cell culture model, resulting in certain cell-cell and cell-matrix interactions not occurring. These extracellular matrix components and interactions are critical for cell differentiation, cell proliferation, and/or cellular functions that normally occur in vivo. Second, it has been found that the environment of two-dimensional cell culture models does not accurately mimic the environment in which living three-dimensional (3D) cancer cells reside because of the absence of hypoxic regions, heterogeneous cell populations, distinct regions of cell proliferation, ECM effects, etc. , soluble signaling gradients, and/or differential nutrient and metabolic waste transport.
三维细胞培养模型可以克服二维细胞培养模型的许多局限性,因为三维细胞培养模型更接近于模拟复杂体内条件的特征和环境。有研究表明,较2D细胞培养模型而言,在3D细胞培养模型下测试出的同种肿瘤细胞系抗癌药物敏感性较低。3D cell culture models can overcome many of the limitations of 2D cell culture models because 3D cell culture models more closely mimic the characteristics and environments of complex in vivo conditions. Studies have shown that compared with 2D cell culture models, the same tumor cell lines tested in 3D cell culture models are less sensitive to anticancer drugs.
建立三维细胞培养模型的一种方法是用多孔聚合物和/或生物材料形成三维支架。至少有一项研究确定了约100-400μm细胞培养模型三维支架的最佳孔径。(参考文献Han等,“使用熔体电写支架的孔隙大小对细胞行为的影响”,《生物工程与生物技术前沿》第9卷,第629270条,2021年7月。)这一结果是基于获得良好的细胞营养、细胞生长空间和细胞-支架相互作用(结果取决于特定的细胞系)。One approach to create three-dimensional cell culture models is to form three-dimensional scaffolds from porous polymers and/or biomaterials. At least one study has identified an optimal pore size of approximately 100-400 μm for 3D scaffolds for cell culture models. (Ref. Han et al., "The Effect of Pore Size on Cell Behavior Using a Melt Electrowriting Scaffold", Frontiers in Bioengineering and Biotechnology, Vol. 9, No. 629270, July 2021.) This result is based on Obtain good cell nutrition, cell growth space and cell-scaffold interactions (results depend on specific cell line).
为了实现可重复的结果,需要高精度的制造方法控制孔隙的大小和形状。例如,持续制备直径为100μm的孔隙,至少需要分辨率20μm的制造方法,如微型3D打印。特别是投影微立体印刷(PμSL)和双光子聚合是能够持续生成复杂三维结构的微3D打印技术。此外,这些打印技术可以用生物相容性和/或生物可降解聚合物(如聚乙二醇(PEG)和聚乳酸(PLA))创建3D结构。聚合后,这些聚合物可能是硬的或软的。To achieve reproducible results, high-precision fabrication methods are required to control the size and shape of the pores. For example, the sustained fabrication of pores with a diameter of 100 μm requires fabrication methods with at least 20 μm resolution, such as micro-3D printing. In particular, projection microstereolithography (PμSL) and two-photon polymerization are micro-3D printing techniques capable of consistently generating complex 3D structures. Additionally, these printing techniques can create 3D structures from biocompatible and/or biodegradable polymers such as polyethylene glycol (PEG) and polylactic acid (PLA). After polymerization, these polymers may be hard or soft.
细胞培养过程可以用反应动力学来描述。在稳定状态下,细胞消耗代谢物(如细胞营养物质)的过程通常用MichaelisMenten方程来描述:Cell culture processes can be described by reaction kinetics. In steady state, the process by which cells consume metabolites (such as cellular nutrients) is usually described by the MichaelisMenten equation:
式中v为反应速度,Vmax为代谢物的最大吸收速率,KM为吸收速率为最大吸收速率一半时的代谢物浓度(米凯利斯常数),[S]为代谢物浓度。在Michaelis-Menten动力学中,低浓度时的消耗行为服从一级动力学。这意味着消耗速率与浓度成正比。随着代谢物浓度的增加,消耗行为将逐渐变为零级动力学。这意味着消耗率接近或等于最大速度,与代谢物浓度无关。这是因为细胞最终达到饱和,因此它们对代谢物的摄入达到一个平台期。此项目提出的生物反应器的几种实施例中,使用毛细管将代谢物输送到生物反应器内的细胞,这样即使当细胞被密集填充时,细胞也能够实现对代谢物的最大吸收从而实现生理性功能。In the formula, v is the reaction speed, V max is the maximum absorption rate of metabolites, K M is the concentration of metabolites when the absorption rate is half of the maximum absorption rate (Michelis constant), and [S] is the concentration of metabolites. In Michaelis-Menten kinetics, the consumption behavior at low concentrations obeys first-order kinetics. This means that the consumption rate is directly proportional to the concentration. As the concentration of metabolites increases, the consumption behavior will gradually change to zero-order kinetics. This means that the consumption rate is close to or equal to the maximal velocity, independent of the metabolite concentration. This is because cells eventually reach saturation, so their uptake of metabolites reaches a plateau. Several embodiments of bioreactors proposed in this project use capillary tubes to transport metabolites to cells within the bioreactor so that even when cells are densely packed, cells can achieve maximum uptake of metabolites for physiological sexual function.
在体内环境下,当细胞浓度在1010/ml量级时,细胞与毛细管的距离小于100μm。为了向这样高密度的细胞群提供代谢物,需要高密度的营养运输通道(毛细管)。In the in vivo environment, when the cell concentration is on the order of 10 10 /ml, the distance between the cell and the capillary is less than 100 μm. In order to provide metabolites to such high density cell populations, a high density of nutrient transport channels (capillaries) is required.
发明内容Contents of the invention
为了解决上述技术问题,本发明所述公开了3D细胞培养灌注生物反应器的应用体系和方法,该反应器具有毛细管系统,以促进3D细胞与细胞之间和细胞与ECM之间的相互作用,以及促进代谢物和代谢废物的运输。为了达到上述发明的目的,本发明采用如下技术方案:In order to solve the above technical problems, the present invention discloses the application system and method of a 3D cell culture perfusion bioreactor, which has a capillary system to promote the interaction between 3D cells and cells and between cells and ECM, As well as facilitating the transport of metabolites and metabolic waste. In order to achieve the purpose of the foregoing invention, the present invention adopts the following technical solutions:
3D细胞培养灌注生物反应器的应用体系,包括:The application system of 3D cell culture perfusion bioreactor, including:
生物反应器,所述生物反应器的顶表面上设置有腔体,所述腔体作为主室,用以对细胞进行培养;所述生物反应器的底部设置有多个底部开口,所述底部开口与所述主室相连接;所述生物反应器还设置有与所述主室连通的进液口和出液口;A bioreactor, the top surface of the bioreactor is provided with a cavity, and the cavity is used as a main chamber for culturing cells; the bottom of the bioreactor is provided with a plurality of bottom openings, and the bottom The opening is connected to the main chamber; the bioreactor is also provided with a liquid inlet and a liquid outlet communicating with the main chamber;
所述主室内设置有若干毛细管,所述毛细管设置在靠近所述底部开口一侧;Several capillaries are arranged in the main chamber, and the capillaries are arranged on a side close to the bottom opening;
所述主室内还设置有多个支撑构件,所述支撑构件用以对所述毛细管进行支撑;部分所述毛细管纵向穿过所述支撑构件与所述进液口连接,用以接收液体;剩余部分所述毛细管纵向穿过所述支撑构件与所述出液口连接,用以排出液体。The main chamber is also provided with a plurality of support members, and the support members are used to support the capillary; part of the capillary longitudinally passes through the support member and is connected to the liquid inlet to receive liquid; A part of the capillary passes longitudinally through the support member and is connected to the liquid outlet for discharging liquid.
进一步地,所述生物反应器的宽度方向与所述主室的宽度方向平行设置,所述生物反应器的长度方向与所述主室的长度方向平行设置。Further, the width direction of the bioreactor is parallel to the width direction of the main chamber, and the length direction of the bioreactor is parallel to the length direction of the main chamber.
进一步地,所述支撑构件为支撑壁,所述支撑壁与所述毛细管相交且垂直,以对所述毛细管提供结构支撑;所述支撑壁设置有多个贯穿孔,用于支撑壁两侧的细胞相互作用。Further, the support member is a support wall, and the support wall intersects and is perpendicular to the capillary to provide structural support for the capillary; the support wall is provided with a plurality of through holes for the two sides of the support wall. cell interaction.
进一步地,相邻的所述毛细管通过回流进行液体交换形成多个回流室,所述回流室中的所述毛细管的第一列与第二列进行液体交换,第三列与第四列进行液体交换…,所述毛细管的第i列与第i+1列进行液体交换,依次类推;Further, the adjacent capillaries perform liquid exchange through reflux to form a plurality of reflux chambers, the first column of the capillary in the reflux chamber performs liquid exchange with the second column, and the third column and the fourth column perform liquid exchange. Exchange..., the i-th column of the capillary performs liquid exchange with the i+1-th column, and so on;
其中,所述回流室中的第i列所述毛细管为动脉毛细管,用于输进液体进行回流,第i+1列所述毛细管为静脉毛细管,用于输出液体;Wherein, the capillary in the i-th column in the reflux chamber is an arterial capillary, which is used to input liquid for reflux, and the capillary in the i+1th column is a venous capillary, which is used to output liquid;
所述动脉毛细管与所述进液口连接,所述静脉毛细管与所述出液口连接。The arterial capillary is connected with the liquid inlet, and the venous capillary is connected with the liquid outlet.
进一步地,所述生物反应器还包括进液室和出液室,所述动脉毛细管通过所述进液室与所述进液口连接,所述静脉毛细管通过所述出液室与所述出液口连接。Further, the bioreactor also includes a liquid inlet chamber and a liquid outlet chamber, the arterial capillary is connected to the liquid inlet through the liquid inlet chamber, and the venous capillary is connected to the outlet through the liquid outlet chamber. Liquid port connection.
进一步地,所述出液口与所述进液口设置在所述生物反应器同一纵向方向上,所述出液室至少部分比进液室高,用于避免空气或其他气体进入毛细管。Further, the liquid outlet and the liquid inlet are arranged in the same longitudinal direction of the bioreactor, and the liquid outlet chamber is at least partly higher than the liquid inlet chamber to prevent air or other gases from entering the capillary.
进一步地,还包括边池和观察窗,所述边池与所述观察窗连接形成培养腔,所述培养腔内设置有培养室,所述培养室内设置有培养基;Further, it also includes a side pool and an observation window, the side pool is connected with the observation window to form a culture cavity, the culture cavity is provided with a culture room, and the culture room is provided with a culture medium;
所述生物反应器放置在所述培养腔内,所述观察窗至少部分与所述底部开口重叠,所述毛细管浸没在所述培养室中;The bioreactor is placed in the culture chamber, the observation window at least partially overlaps the bottom opening, and the capillary is submerged in the culture chamber;
所述边池靠近所述进液室一面设置有输入端口,所述边池靠近所述出液室一面设置有输出端口;所述输入端口与所述进液口连接,所述输入端口的远离所述进液口的一端与进液泵连接;所述输出端口与所述出液口连接,所述输出端口的远离所述出液口的一端与出液池连接;An input port is provided on the side of the side tank close to the liquid inlet chamber, and an output port is provided on the side of the side tank close to the liquid outlet chamber; the input port is connected to the liquid inlet, and the distance between the input port and the One end of the liquid inlet is connected to the liquid inlet pump; the output port is connected to the liquid outlet, and the end of the output port far away from the liquid outlet is connected to the liquid outlet pool;
所述输入端口与所述进液口连接处设置有进液阀;所述输出端口与所述出液口连接处设置有出液阀。A liquid inlet valve is arranged at the connection between the input port and the liquid inlet; a liquid outlet valve is arranged at the connection between the output port and the liquid outlet.
进一步地,所述动脉毛细管与所述静脉毛细管中至少一个设置有微孔;所述毛细管的密度为3-30毛细管/mm2;所述生物反应器的至少部分是使用投影微立体光刻和双光子聚合进行3D打印的。Further, at least one of the arterial capillary and the venous capillary is provided with micropores; the density of the capillary is 3-30 capillary/mm 2 ; at least part of the bioreactor is made using projection micro-stereolithography and 3D printing by two-photon polymerization.
细胞培养方法,包括以下步骤:A cell culture method comprising the steps of:
将生物反应器放置在培养腔中,其中,生物反应器中的毛细管浸没在培养室的培养基中进行细胞培养;在主室内接种细胞,培养细胞,并将培养基从进液口泵入,所产生的代谢废物从出液口输出进入出液池;利用显微镜通过观察窗进行观察;Place the bioreactor in the culture chamber, where the capillary in the bioreactor is submerged in the culture medium in the culture chamber for cell culture; inoculate the cells in the main chamber, cultivate the cells, and pump the culture medium from the liquid inlet, The metabolic waste produced is output from the liquid outlet into the liquid outlet pool; use a microscope to observe through the observation window;
在生物反应器中接种细胞后,可将其放入培养箱中,在培养箱中可控制环境条件以促进或阻止细胞生长和/或增殖。After seeding cells in a bioreactor, they can be placed in an incubator where environmental conditions can be controlled to promote or prevent cell growth and/or proliferation.
有益效果:Beneficial effect:
以促进3D细胞与细胞之间和细胞与ECM之间的相互作用,以及促进代谢物和代谢废物的运输。本发明适合于高密度3D细胞培养。这种基于灌注的3D生物反应器可以更精确地模拟体内生物条件和细胞行为,有助于提高药物的开发。灌注型3D生物反应器的部分或全部结构可以通过PμSL微3D打印和双光子聚合技术来实现。To facilitate 3D cell-to-cell and cell-to-ECM interactions, as well as to facilitate the transport of metabolites and metabolic waste. The invention is suitable for high-density 3D cell culture. This perfusion-based 3D bioreactor can more accurately simulate in vivo biological conditions and cell behavior, helping to improve drug development. Part or all of the structure of the perfusion 3D bioreactor can be realized by PμSL micro 3D printing and two-photon polymerization technology.
附图说明Description of drawings
图1为生物反应器结构示意图。Figure 1 is a schematic diagram of the bioreactor structure.
图2为生物反应器底部结构示意图。Figure 2 is a schematic diagram of the bottom structure of the bioreactor.
图3为毛细管的典型排列示意图。Figure 3 is a schematic diagram of a typical arrangement of capillaries.
图4为生物反应器的横截面图。Figure 4 is a cross-sectional view of a bioreactor.
图5为回流室截面图。Fig. 5 is a sectional view of the reflux chamber.
图6为出液室与进液室的侧视图。Fig. 6 is a side view of the liquid outlet chamber and the liquid inlet chamber.
图7为出液室与进液室正视图。Fig. 7 is a front view of the liquid outlet chamber and the liquid inlet chamber.
图8为出液室与进液室位置示意图。Fig. 8 is a schematic diagram of the positions of the liquid outlet chamber and the liquid inlet chamber.
图9为研究细胞生物学和/或组织工程学实验示例图。Fig. 9 is a diagram illustrating an example of an experiment for studying cell biology and/or tissue engineering.
其中:10:生物反应器;20:主室;30:底部开口;40:进液口;50:出液口;100:毛细管;102:动脉毛细管;104:静脉毛细管;110:支撑壁;120:贯通孔;130:回流;200:回流室;210:进液室;220:出液室;300:进液泵;310:出液池;320:进液阀;330:出液阀;400:边池;410:观察窗;420:培养室;500:显微镜。Among them: 10: bioreactor; 20: main chamber; 30: bottom opening; 40: liquid inlet; 50: liquid outlet; 100: capillary; 102: arterial capillary; 104: venous capillary; 110: support wall; 120 : through hole; 130: return flow; 200: return chamber; 210: liquid inlet chamber; 220: liquid outlet chamber; 300: liquid inlet pump; 310: liquid outlet pool; 320: liquid inlet valve; 330: liquid outlet valve; 400 : side pool; 410: observation window; 420: culture room; 500: microscope.
具体实施方式Detailed ways
以下将结合附图对本发明各实施例的技术方案进行清楚、完整的描述,显然,所描述的实施例仅仅是本发明的一部分实施例,而不是全部的实施例。基于本发明的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所得到的所有其它实施例,都属于本发明所保护的范围。The technical solutions of the various embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts fall within the protection scope of the present invention.
下面通过具体的实施例子并结合附图对本发明做进一步的详细描述。The present invention will be described in further detail below through specific implementation examples and in conjunction with the accompanying drawings.
实施例1Example 1
3D细胞培养灌注生物反应器的应用体系,包括:The application system of 3D cell culture perfusion bioreactor, including:
生物反应器10,生物反应器10的顶表面上设置有腔体,腔体作为主室20,用以对细胞进行培养;生物反应器10的底部设置有多个底部开口30,底部开口30与主室20相连接;生物反应器10还设置有与主室20连通的进液口40和出液口50;
主室20内设置有若干毛细管100,毛细管100设置在靠近底部开口30一侧;主室20内还设置有多个支撑构件,支撑构件用以对毛细管100进行支撑,毛细管100纵向穿过支撑构件与主室20连接,并从主室20的一端延伸到主室20的另一端;部分毛细管100与进液口40连接,用以接收液体;剩余部分毛细管100与出液口50连接,用以排出液体。
优选的,主室20为碗状形,主室20的开口顶部边缘与生物反应器10的顶表面相邻,主室20尺寸大约为10毫米长、6毫米宽、5毫米深;生物反应器10的长度方向与主室20的长度方向平行设置,生物反应器10的宽度方向与主室20的宽度方向平行设置。Preferably, the
在本实施例中,设置有五层毛细管100,每层有14个独立的毛细管100,共70个毛细管。在其它实施例中,每个毛细管100的外径为100μm,内径为80μm;毛细管100相邻外表面间距为0.4mm;毛细管100的等效横截面密度为4毛细管/mm2。In this embodiment, five layers of
优选的,将毛细管100排成列对齐状有利于观察其中的细胞和/或组织,使用显微镜从下方底部开口30观察,较低的毛细管100(靠近底部开口30)不会阻塞较高的毛细管100(远离底部开口30)之间的水平空间。Preferably, arranging the capillary 100 in a row is conducive to observing the cells and/or tissues therein, and using a microscope to observe from the
在其它实施例中,可利用其他的毛细管排列、方向、尺寸和密度。在其它实施例中,部分或全部毛细管100可布置成纵向、横向和/或对角线穿过主室20;在其它实施例中,部分或全部毛细管100可平行定向和/或以不同角度相互定向;在其它实施例中,部分或全部毛细管100可能具有不同的内径、外径和壁厚;在其它实施例中,部分或全部毛细管100之间可能有不同的间距;在其它实施例中,毛细管的横截面密度可为大约3-30个毛细管/mm2。In other embodiments, other capillary arrangements, orientations, sizes and densities may be utilized. In other embodiments, some or all of the
优选的,支撑构件为支撑壁110,支撑壁110与毛细管100相交且垂直,以对毛细管100提供结构支撑;支撑壁110设置有多个贯穿孔120,用于支撑壁110两侧的细胞相互作用。Preferably, the support member is a
在本实施例中,支撑壁110的数量取决于毛细管100的外径、壁厚和材料,毛细管100纵向延伸穿过一个10mm长的主室,每个毛细管的外径为100μm,壁厚为10μm,由聚乙二醇构成,需要7个等间距的支撑壁来充分支撑毛细管。在其它实施例中,相邻毛细管100之间的间距大约比毛细管100的外径大一个数量级,可用单个垂直和/或水平的支撑构件支撑毛细管100。In this embodiment, the number of
在本实施例中,贯通孔120的直径为200μm,贯通孔120为穿过支撑壁110的均匀间距圆形孔。在其它实施例中,贯通孔120也可以采用其他间距和形状。In this embodiment, the diameter of the through
优选的,相邻的毛细管100通过回流进行液体交换形成多个回流室200,回流室200中的毛细管100的第一列与第二列液体进行交换,第三列与第四列液体交换…,所述毛细管的第i列与第i+1列进行液体交换,依次类推;Preferably, adjacent
其中,回流室200其中第i列毛细管100为动脉毛细管102,用于输出液体;第i+1列毛细管100为静脉毛细管104,用于输出液体;Wherein, in the
动脉毛细管102与进液口40连接,静脉毛细管104与出液口50连接。The
在本实施例中,在动脉毛细管102和相邻静脉毛细管104之间有七个回流室,每个包含七个回流。在其它实施例中,每个回流室可由单个动脉毛细管102和单个静脉毛细管104之间的单个回流组成。In this embodiment, there are seven flashback chambers between the
优选的,生物反应器10还包括进液室210和出液室220,动脉毛细管102通过进液室210与进液口40连接,静脉毛细管104通过出液室220与出液口50连接。Preferably, the
优选的,出液口50与进液口40设置在生物反应器10同一纵向方向上,出液室220至少部分比进液室210高,用于避免空气或其他气体进入毛细管;在出液口50的最高部分或其附近连接到出液室220可能是有利的。Preferably, the
优选的,包括边池400和观察窗410,边池400与观察窗410连接形成培养腔,培养腔内设置有培养室420,培养室420内设置有培养基;Preferably, it includes a
生物反应器10放置在培养腔内,观察窗410至少部分与底部开口30重叠,毛细管100浸没在培养室420中;The
边池400靠近进液室210一面设置有输入端口,边池400靠近出液室220一面设置有输出端口;输入端口与进液口40连接,输入端口的远离进液口40的一端与进液泵300连接;输出端口与出液口50连接,输出端口的远离出液口50的一端与出液池310连接;The
输入端口与进液口40连接处设置有进液阀320;输出端口与出液口50连接处设置有出液阀330;输入端口与进液口40连接处和输出端口与出液口50连接处设置有O形环,以防止液体泄漏。The connection between the input port and the
在其它实施例中,出液池310可连通到废物处理装置,用于将代谢废物与营养物分离,并且可有将回收价值的代谢物运输到进液口40进行再循环。废物处理装置可将回收的代谢物运输到回收的储存库,可通过泵送或重力从其中提取回收的营养物。在泵送的情况下,进液泵300可以将回收的和/或再加工的代谢物从回收存储库运输到进液口40,或者,第二个泵可以将回收和/或再加工的代谢物运输到进液口40或新鲜存储库。In other embodiments, the
优选的,动脉毛细管102与静脉毛细管104中至少一个设置有微孔。Preferably, at least one of the
溶质穿过膜(如毛细管管壁)的渗透率与溶质穿过膜的浓度梯度成正比。因此,选择毛细管100的壁厚和/或材料,以允许某些溶质(包括代谢物和代谢废物)以适当的速率进入和离开毛细管100。如果主室20中的代谢废物浓度过高(例如,约100μmol/L),主室20中细胞的健康可能会受到影响。代谢废物可能包括氮化合物等毒素。同样,如果主室20内营养物的浓度过低,细胞可能无法增殖和/或生长,或者细胞可能会饥饿和/或死亡。因此,为主室20提供足够的营养物并不断清除代谢废物是很重要的,可通过在毛细管100壁上添加微孔来增加通过毛细管壁(对于代谢物和代谢废物的一种或两者)的扩散。The permeability of a solute across a membrane (such as the wall of a capillary) is directly proportional to the concentration gradient of the solute across the membrane. Accordingly, the wall thickness and/or material of the capillary 100 is selected to allow certain solutes, including metabolites and metabolic wastes, to enter and exit the capillary 100 at an appropriate rate. If the concentration of metabolic waste in the
在本实施例中,直径约为5-15μm的微孔可以添加到毛细管100的壁上,以显著增加扩散速率(s)。In this embodiment, micropores with a diameter of approximately 5-15 μm can be added to the wall of the capillary 100 to significantly increase the diffusion rate (s).
在其它实施例中,添加到动脉毛细管102的微孔的直径和/或密度(间隔)可能不同于添加到静脉毛细管104的微孔的直径和/或密度(间隔)。In other embodiments, the diameter and/or density (spacing) of micropores added to
在其它实施例中,微孔可以只添加到动脉毛细管102或只添加到静脉毛细管104,或只添加到其中的选定部分。In other embodiments, micropores may be added only to the
当培养基在毛细管内运输时,代谢物可能通过毛细管100壁扩散出去,在那里它们可能被主室内的细胞消耗。因此,消耗代谢物的细胞可能产生和释放代谢废物,这些废物可能通过毛细管壁扩散进入并被运输。动脉毛细管102将新鲜培养基从进液室210运输到回流室200,静脉毛细管104将培养基从回流室200运输到出液室220。因此,扩散到毛细管100的代谢废物被运输到其中的出液室220,而扩散到动脉毛细管102的代谢废物被运输到回流室,在那里它将进入毛细管100,随后被运输到出液室220。毛细管100内的流速为每秒几毫米量级。As the medium is transported within the capillary, metabolites may diffuse out through the walls of the capillary 100 where they may be consumed by cells within the main chamber. Thus, cells that consume metabolites may generate and release metabolic waste products that may enter and be transported by diffusion through capillary walls. The
优选的,在本实施例中生物反应器10的至少部分是使用投影微立体光刻和双光子聚合进行3D打印的。Preferably, at least part of the
在其它实施例中,生物反应器由I类或更高的生物相容性材料指标或打印,如聚乙二醇(PEG,分子量575)。有些材料可能需要进行表面处理以促进细胞粘附,这对于需要模型细胞附着在生物反应器表面并在其表面增殖的细胞培养实验可能很重要。聚l-赖氨酸溶液可用于覆盖生物反应器的一个或多个表面,覆盖主室20的一个或多个表面。In other embodiments, the bioreactor is indexed or printed from a Class I or higher biocompatible material, such as polyethylene glycol (PEG, molecular weight 575). Some materials may require surface treatment to promote cell adhesion, which may be important for cell culture experiments that require model cells to attach to and proliferate on the surface of a bioreactor. The poly-l-lysine solution can be used to coat one or more surfaces of the bioreactor, covering one or more surfaces of the
实施例2Example 2
细胞培养方法,采用实施例1提供的3D细胞培养灌注生物反应器的应用体系,该方法包括:Cell culture method, adopt the application system of the 3D cell culture perfusion bioreactor that embodiment 1 provides, this method comprises:
将生物反应器10放置在培养腔中,其中,生物反应器10中的毛细管100浸没在培养室420的培养基中进行细胞培养;在主室20内接种细胞,培养细胞,并将培养基从进液口泵入,所产生的代谢废物从出液口50输出进入出液池310;利用显微镜通过观察窗进行观察;The
在生物反应器10中接种细胞后,可将其放入培养箱中,在培养箱中可控制环境条件以促进或阻止细胞生长和/或增殖。After seeding cells in
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。不应将权利要求中的任何附图标记视为限制所涉及的权利要求。It will be apparent to those skilled in the art that the invention is not limited to the details of the above-described exemplary embodiments, but that the invention can be embodied in other specific forms without departing from the spirit or essential characteristics of the invention. Accordingly, the embodiments should be regarded in all points of view as exemplary and not restrictive, the scope of the invention being defined by the appended claims rather than the foregoing description, and it is therefore intended that the scope of the invention be defined by the appended claims rather than by the foregoing description. All changes within the meaning and range of equivalents of the elements are embraced in the present invention. Any reference sign in a claim should not be construed as limiting the claim concerned.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211446147.4A CN116121068A (en) | 2022-11-18 | 2022-11-18 | Application system of 3D cell culture perfusion bioreactor and cell culture method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211446147.4A CN116121068A (en) | 2022-11-18 | 2022-11-18 | Application system of 3D cell culture perfusion bioreactor and cell culture method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116121068A true CN116121068A (en) | 2023-05-16 |
Family
ID=86305304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211446147.4A Pending CN116121068A (en) | 2022-11-18 | 2022-11-18 | Application system of 3D cell culture perfusion bioreactor and cell culture method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116121068A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025175072A1 (en) * | 2024-02-16 | 2025-08-21 | Bmf Precision, Inc. | System and method of perfusion 3d cell culture |
-
2022
- 2022-11-18 CN CN202211446147.4A patent/CN116121068A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025175072A1 (en) * | 2024-02-16 | 2025-08-21 | Bmf Precision, Inc. | System and method of perfusion 3d cell culture |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3652290B1 (en) | 3d cell culture vessels for manual or automatic media exchange | |
| US5516691A (en) | Module for culturing and using metabolisms and/or for maintaining microorganisms | |
| Bruzewicz et al. | Fabrication of a modular tissue construct in a microfluidic chip | |
| US8748180B2 (en) | Microfluidic device for pharmacokinetic-pharmacodynamic study of drugs and uses thereof | |
| Sbrana et al. | Engineering Quasi-Vivo® in vitro organ models | |
| Jasmund et al. | Cultivation of primary porcine hepatocytes in an OXY‐HFB for use as a bioartificial liver device | |
| CN101611133A (en) | Efficient device and method for culturing cells | |
| JP2004147555A (en) | Cell culture apparatus, bioreactor and cell culture chamber | |
| US20110003359A1 (en) | Biodevice | |
| Korin et al. | Design of well and groove microchannel bioreactors for cell culture | |
| CN115340948A (en) | Microfluidic chip for co-culturing multiple hepatocytes in layer-by-layer overlapping manner and application of microfluidic chip | |
| CN116121068A (en) | Application system of 3D cell culture perfusion bioreactor and cell culture method | |
| CN204644371U (en) | A kind of integrated form many cells noncontact co-culture device | |
| CN114585724A (en) | cell culture device | |
| CN111748470B (en) | 3D high-flux organ microchip and preparation method and application thereof | |
| CN100540647C (en) | Slot-shaped perforated plate animal cell hollow fiber reactor and its application | |
| CN117229917A (en) | Pump-driving-free organoid chip | |
| CN101724557A (en) | Polysaccharide composite stent perfusion type liver cell reactor system for use in medicament-induced hepatotoxicity evaluation | |
| CN110734858A (en) | multi-mode three-dimensional perfusion type cell culture instrument | |
| CN205473829U (en) | Interact's culture apparatus between cell culture and cell | |
| CN115678778A (en) | Micro-fluidic chip device for culturing three-dimensional cell clusters | |
| CA2372219A1 (en) | Modular cell support systems for the three-dimensional cell growth | |
| WO2024044348A1 (en) | System and method for perfusion bioreactor for 3d cell culture | |
| FI129674B (en) | Apparatus and method for cell cultivation | |
| CN222574674U (en) | A culture chip and automated culture system based on open chamber patterned array microfluidics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20250306 Address after: 518000 Room 501, building 8, Jinxiu Dadi, 118 hudipai, songyuanxia community, Guanhu street, Longhua District, Shenzhen City, Guangdong Province Applicant after: BMF NANO MATERIAL TECHNOLOGY Co.,Ltd. Country or region after: China Address before: Room 507, 5th Floor, Building A, Zhongguancun Science and Technology Development Building, No. 32 Zhongguancun South Street, Haidian District, Beijing, 100191 Applicant before: Sun Yuchun Country or region before: China Applicant before: Xia Chunguang |
|
| TA01 | Transfer of patent application right |